|Source: ||Semisynthetic derivate of Cytochalasin B, obtained from Drechslera dematoidea.|
|Description: || |
|CAS number: ||39156-67-7|
|Merck index: ||13: 2819|
|Molecular weight: ||481.6|
|Molecular Formula: ||C29H39NO5|
|Acetone, DMSO, 100% Ethanol, Methanol|
|Appearance: ||White powder|
|Purity: ||At least 98% by TLC, HPLC|
|Melting point||203ºC - 205ºC|
|Solubility||Clear colorless solution at 10mg/ml Methanol|
|Storage||-20°C. Protect from light.|
|Applications||Cytochalasins are used as tools in cytological research, and in in the field of actin polymerisation|
|Warnings||TOXIC. POTENTIAL CARCINOGEN. HARMFUL IF SWALLOWED|
|Classification||Macrolide indol mycotoxin|
Cytochalasin A, Cytochalasin B, Dihydro-Cytochalasin B, Cytochalasin C, Cytochalasin D, Cytochalasin E
| ||For Research use only. Not for Human or Drug use|
GMP/API grade available on request
Dihydrocytochalasin B by Fermentek is not produced from or contains any ingredients from animal origin.
No genetically modified organisms are used.
| ||Dijkstra J, van Galen M, Scherphof G.|
Effects of dihydro-cytochalasin B, colchicine, monensin and trifluoperazine on uptake and processing of liposomes by Kupffer cells in culture.
Biochim Biophys Acta. 1985 Apr 22;845(1):34-42
| ||Freyria AM, Ronziere MC, Roche S, Rousseau CF, Herbage D.|
Regulation of growth, protein synthesis, and maturation of fetal bovine epiphyseal chondrocytes grown in high-density culture in the presence of ascorbic acid, retinoic acid, and dihydrocytochalasin B.
J Cell Biochem. 1999 Nov;76(1):84-98.
| ||PD Benya, PD Brown and SR Padilla|
Microfilament modification by dihydro-cytochalasin B causes retinoic acid-modulated chondrocytes to reexpress the differentiated collagen phenotype without a change in shape
The Journal of Cell Biology, Vol 106, 161-170